|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1341 - 0.1476|
|52 Week Range||0.1050 - 0.7870|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2019) - THC BioMed (CSE: THC) (OTCQB: THCBF) (FSE: TFHD), a licensed cannabis producer and Canada's largest supplier of legal Cannabis Genetics, has submitted a new product application to Health Canada for THC BioMed's Pure Cannabis Sticks. Pure Cannabis Sticks, which are filtered, paper cylinders filled with pure THC BioMed cannabis, will be manufactured using THC BioMed's automated production machine.InvestmentPitch.com has produced a "video" which discusses ...
VANCOUVER , Sept. 17, 2019 /CNW/ - THC BioMed Intl Ltd. ("THC BioMed" or the "Company") announces that it has submitted a new product application to Health Canada for THC BioMed's Pure Cannabis Sticks. Pure Cannabis Sticks are filtered, paper cylinders filled with pure THC BioMed cannabis. Pure Cannabis Sticks are to be manufactured using THC BioMed's automated production machine.
VANCOUVER, Sept. 9, 2019 /PRNewswire/ - THC BioMed Intl Ltd. ("THC" or the "Company") (THC.CN) announces that Health Canada has completed an inspection at its flagship Acland road facility. "This inspection brings us a step closer to supplying adult Canadian Cannabis users with an alternative, brand-new product THC Kiss," commented John Miller, CEO of THC.
VANCOUVER, July 9, 2019 /PRNewswire/ - THC BioMed Intl Ltd. ("THC BioMed", or the "Company") (THC.CN) is pleased to announce that it has received Health Canada's approval to proceed with production in 3 additional strata lots at its flagship location on Acland Road in Kelowna B.C. "The granting of the 3 additional Strata lots will actually double our approved growing space and makes a significant change for THC BioMed. This is a major milestone," said John Miller, President and CEO of THC BioMed.
The filters are natural, rapidly degrading and commercial-quality, using raw materials that include flax, cotton, and manila hemp with no artificial compounds. The manufacturer advises that the average time for degradation of these patented filters is 3 days in compost or 2 minutes when dispersed in water at 150 rpm agitation. In comparison, it can take up to 15 years for common acetate filters to degrade.
Seattle, Washington--(Newsfile Corp. - June 19, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing THC BioMed (CSE: THC) (OTCQX: THCBF).Automated pre-rolled CannabisTo view an enhanced version of this graphic, please visit:https://orders.newsfilecorp.com/files/5503/45716_m5d094ac106fe68000467d5d5_1.jpgCannabis in Canada has a long and storied history, going back to 1923 when the plant was added to the Confidential Restricted List as a ...
Vancouver, British Columbia--(Newsfile Corp. - June 12, 2019) - THC BioMed (CSE: THC) (OTCQB: THCBF) (FSE: TFHD), a licensed cannabis producer and Canada's largest supplier of legal Cannabis Genetics, has launched a line of pre-rolled cigarettes containing 100% cannabis. The company, the first Canadian Licensed Producer to automate the pre-rolling of cigarettes, is confident this change will bring meaningful changes to the current cannabis industry and its bottom line, similar to the way automation ...
VANCOUVER, June 11, 2019 /PRNewswire/ - THC BioMed Intl Ltd. ("THC BioMed", or the "Company") (THC.CN) is pleased to announce that it is the first Canadian Licensed Producer to automate the pre-rolling of cigarettes containing 100% cannabis (the "Pure Cannabis Cigarettes"). In the same way automation changed the tobacco industry, THC BioMed is confident the automation of Pure Cannabis Cigarettes will bring meaningful changes to the current cannabis industry and its bottom line. The automated cigarette manufacturing plant has been installed at THC BioMed's flagship Acland Road location. THC will begin the production and sales of commercial-grade Pure Cannabis Cigarettes, a first in Canada.
NEW YORK , June 4, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...
VANCOUVER , May 29, 2019 /CNW/ - THC BioMed Intl Ltd. ("THC" or the "Company") (THC.CN) announces that it has entered into a line of credit with President, CEO and director John Miller for up to $500,000 (the "Line of Credit"). Each separate draw down of funds from the Line of Credit ("Draw Down Amount") will not bear interest for the first three calendar months following its withdrawal. The Interest will be calculated and payable monthly, on the last business day of each month until the Line of Credit is repaid in full.
VANCOUVER, May 22, 2019 /PRNewswire/ - THC BioMed Intl Ltd. ("THC", or the "Company") (THC.CN) announces that they are engaging CFN Media to conduct a 6-month investor and market visibility program beginning towards the end of May, 2019. CFN Media will leverage its powerful content platform and extensive reach into mainstream and cannabis-focused investor audiences and media across North America to educate high-quality investors on THC's value proposition. CFN Media's program will measure investor engagement and identify interested investors via opt-in leads while elevating the Company's financial brand.
VANCOUVER , May 22, 2019 /CNW/ - THC BioMed Intl Ltd. (THC.CN), ("THC" or the "Company") announces that John Miller , President, Chief Executive Officer and director of the Company, plans to purchase up to 500,000 additional common shares (the "Shares") in the capital of the Company. Mr. Miller is purchasing the Shares for investment purposes, and commented, "I am very satisfied with the progress THC BioMed has made to become a profitable company." He currently holds 25,318,071 of the 146,379,363 issued and outstanding common shares in the capital of the Company representing 17.3%.
VANCOUVER, May 9, 2019 /PRNewswire/ - THC BioMed Intl Ltd. ("THC", "THC BioMed" or the "Company") (THC.CN) THC BioMed is pleased to report that it has entered into an agreement with the BC Liquor Distribution Branch ("BCLDB") to supply a number of its products exclusively to British Columbia. The agreement was entered into after the BC Liquor Distribution Branch (BCLDB) met with THC BioMed management and toured THC's flagship facility in Kelowna B.C. The BCLDB will provide purchase orders to THC BioMed for the product quantities listed in the appendix to the agreement three months in advance of the available supply month.
VANCOUVER , April 9, 2019 /CNW/ - THC BioMed Intl Ltd. ("THC" or the "Company") (THC.CN) announces that it has received Health Canada permission to commence cannabis production in two additional strata lots at THC BioMed's flagship location in Kelowna, B.C. The newly licensed strata lots will allow THC to begin automation of its systems allowing more efficient production, while increasing margins. THC now has 11 strata lots licensed for production, 3 additional strata lots are being submitted for review by Health Canada, while a further 3 strata lots are currently under construction.